Table 2 The primers applied in current study.

From: Cell fate determined by the activation balance between PKR and SPHK1

Gene

Primer

SPHK1a

Sense

CCCAAGCTTATGGATCCAGCGGGCGGCCC

Antisense

CCGCTCGAGATGGATCCAGCGGGCGGCCC

PKRa

Sense

CGCGGATCCATGGCTGGTGATCTTTCAG

Antisense

CCCAAGCTTACATGTGTGTCGTTCATTTT

SPHK1b

Sense

CCGGAATTCATGGATCCAGCGGGCGGCCC

Antisense

CCGCTCGAGTCAATGGATCCAGCGGGCGGC

PKRb

Sense

CGCGCATCCATGGCTGGTGATCTTTCAGCA

Antisense

CCGCTCGAGCTAACATGTGTGTCGTTCATTTT

D1c

Sense

CTAGTCTAGAATGGCTGGTGATCTTTCAGC

Antisense

CCCAAGCTTCAAAGATCTTTTTGCCTTCCTTTG

D2c

Sense

CTAGTCTAGAATGCGTGTTAAATATAATAACGA

Antisense

CCCAAGCTTACATGTGTGTCGTTCATTTTTCT

S1PR1d

Sense

GCCTACACAGCTAACCTGCTCTTG

Antisense

TGGCGATGGCGAGGAGACTG

S1PR2d

Sense

CCACCACCTCCTGCCACTCC

Antisense

CACCGTGTTGCCCTCCAGAAAC

S1PR3d

Sense

GATCCTCTACGCACGCATCTACTTC

Antisense

ACACGCTCACCACAATCACCAC

GAPDHd

Sense

AACGGATTTGGTCGTATTGG

Antisense

GATTTTGGAGGGATCTCGC

ABCC1d

Sense

CCGTGTTGGTCTCTGTGTTCCTG

Antisense

AAGTCGGCGGCGTAATTCTTAGC

SPNS2d

Sense

GTTACTGGCTGGCTGTGGCTTC

Antisense

GCAACACTCGGACCTGGTTCTTG

  1. aPrimers used for eukaryotic plasmids construction.
  2. bPrimers used for prokaryotic plasmids construction.
  3. cPrimers used for truncated plasmids construction.
  4. dPrimers used for quantitative RT-PCR.